CRESEMBA
NDC 0469-2860, isavuconazonium sulfate, capsule, from Astellas Pharma US, Inc..
- Product NDC
- 0469-2860
- Status
- Listed
- Labeler
- Astellas Pharma US, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA207500
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0469-2860 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ISAVUCONAZONIUM SULFATE40 mg/1
Pharmacologic classes
Azole Antifungal [EPC]; Azoles [CS]; Cytochrome P450 3A4 Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0469-2860-35 | 00469286035 | 7 BLISTER PACK in 1 CARTON (0469-2860-35) / 5 CAPSULE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/8f7f73b8-586a-4df0-935f-fecd4696c16c
Use it
Look up 0469-2860 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0469-2860 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0469-2860. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.